Exploring the potential of gold(iii) cyclometallated compounds as cytotoxic agents: variations on the C^N theme

Metallodrugs in Medicinal Inorganic Chemistry

(2014) Katja Dralle Mjos et al.   CHEMICAL REVIEWS

New Gold(I) Organometallic Compounds with Biological Activity in Cancer Cells

(2014) Benoît Bertrand et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Caffeine-Based Gold(I) N-Heterocyclic Carbenes as Possible Anticancer Agents: Synthesis and Biological Properties

(2014) Benoît Bertrand et al.   INORGANIC CHEMISTRY

Gold compounds as aquaporin inhibitors: new opportunities for therapy and imaging

(2014) Andreia de Almeida et al.   MedChemComm

Insights into the Reactivity of Gold-Dithiocarbamato Anticancer Agents toward Model Biomolecules by Using Multinuclear NMR Spectroscopy

(2013) Giulia Boscutti et al.   CHEMISTRY-A EUROPEAN JOURNAL

Aquaporin Inhibition by Gold(III) Compounds: New Insights

(2013) Ana Paula Martins et al.   ChemMedChem

A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds

(2013) Benoît Bertrand et al.   DALTON TRANSACTIONS

TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes

(2013) Riccardo Rubbiani et al.   MedChemComm

Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs

(2012) Wukun Liu et al.   CHEMICAL SOCIETY REVIEWS

Cytotoxic gold compounds: synthesis, biological characterization and investigation of their inhibition properties of the zinc finger protein PARP-1

(2012) Maria Serratrice et al.   DALTON TRANSACTIONS

N-Heterocyclic carbene metal complexes in medicinal chemistry

(2012) Luciano Oehninger et al.   DALTON TRANSACTIONS

Targeting Aquaporin Function: Potent Inhibition of Aquaglyceroporin-3 by a Gold-Based Compound

(2012) Ana Paula Martins et al.   PLoS One

Thiolato gold(i) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties

(2011) Elena Vergara et al.   DALTON TRANSACTIONS

Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity

(2011) Yongbao Zhu et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA

(2011) Filipa Mendes et al.   JOURNAL OF MEDICINAL CHEMISTRY

Gold compounds as therapeutic agents for human diseases

(2011) Susan J. Berners-Price et al.   Metallomics

The status of platinum anticancer drugs in the clinic and in clinical trials

(2010) Nial J. Wheate et al.   DALTON TRANSACTIONS

Organometallic Anticancer Compounds

(2010) Gilles Gasser et al.   JOURNAL OF MEDICINAL CHEMISTRY

On the medicinal chemistry of gold complexes as anticancer drugs

(2009) Ingo Ott   COORDINATION CHEMISTRY REVIEWS

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

(2009) Alberto Bindoli et al.   COORDINATION CHEMISTRY REVIEWS

OLEX2: a complete structure solution, refinement and analysis program

(2009) Oleg V. Dolomanov et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

The DNA-damage response in human biology and disease

(2009) Stephen P. Jackson et al.   NATURE

Zinc metalloproteins as medicinal targets

(2008) A. I. Anzellotti et al.   CHEMICAL SOCIETY REVIEWS